ENTO – entero therapeutics inc. (US:NASDAQ)
Stock Stats
News
Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings
Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q
Entero Therapeutics' Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program [Yahoo! Finance]
Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program
Entero Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds [Yahoo! Finance]
Form 8-K Entero Therapeutics, For: Sep 06
Form 8-K Entero Therapeutics, For: Sep 09
Form 8-K Entero Therapeutics, For: Aug 29
Form 8-K Entero Therapeutics, For: Aug 28
Form 8-K Entero Therapeutics, For: Aug 21
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.